Skip to main content

SOLUCIONES PARA LA MEJORA DE LA EFICIENCIA Y SEGURIDAD DEL PANCREAS ARTIFICIAL MEDIANTE ARQUITECTURAS DE CONTROL MULTIVARIABLE TOLERANTES A FALLOS

DPI2016-78831-C2-2-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2016
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSITAT DE GIRONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 17
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Artificial Pancreas With Carbohydrate Suggestion Performance for Unannounced and Announced Exercise in Type 1 Diabetes

  • Viñals, Clara
  • Beneyto, Aleix
  • Hirata-Bertachi, Arthur
  • Vehí, Josep
  • Conget, Ignacio
  • Giménez, Marga
  • Martín-SanJosé, Juan-Fernando|||0000-0002-3247-6156
  • Furió-Novejarque, Clara|||0000-0003-2923-6618
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Objective: To evaluate the safety and performance of a new multivariable closed-loop (MCL) glucose controller with automatic carbohydrate recommendation during and after unannounced and announced exercise in adults with type 1 diabetes (T1D). Research design and methods: A randomized, 3-arm, crossover clinical trial was conducted. Participants completed a heavy aerobic exercise session including three 15-minute sets on a cycle ergometer with 5 minutes rest in between. In a randomly determined order, we compared MCL control with unannounced (CLNA) and announced (CLA) exercise to open-loop therapy (OL). Adults with T1D, insulin pump users, and those with hemoglobin (Hb)A1c between 6.0% and 8.5% were eligible. We investigated glucose control during and 3 hours after exercise. Results: Ten participants (aged 40.8 +/- 7.0 years; HbA1c of 7.3 +/- 0.8%) participated. The use of the MCL in both closed-loop arms decreased the time spent <70 mg/dL of sensor glucose (0.0%, [0.0-16.8] and 0.0%, [0.0-19.2] vs 16.2%, [0.0-26.0], (%, [percentile 10-90]) CLNA and CLA vs OL respectively; P = 0.047, P = 0.063) and the number of hypoglycemic events when compared with OL (CLNA 4 and CLA 3 vs OL 8; P = 0.218, P = 0.250). The use of the MCL system increased the proportion of time within 70 to 180 mg/dL (87.8%, [51.1-100] and 91.9%, [58.7-100] vs 81.1%, [65.4-87.0], (%, [percentile 10-90]) CLNA and CLA vs OL respectively; P = 0.227, P = 0.039). This was achieved with the administration of similar doses of insulin and a reduced amount of carbohydrates. Conclusions: The MCL with automatic carbohydrate recommendation performed well and was safe during and after both unannounced and announced exercise, maintaining glucose mostly within the target range and reducing the risk of hypoglycemia despite a reduced amount of carbohydrate intake., This work has been partially funded by the Spanish Government under grants DPI2016-78831-C2-1-R, DPI2016-78831-C2-2-R, and FPU0244 2015; by the EU through FEDER funds; by the National Counsel of Technological and Scientific Development, CNPq-Brazil 207688/2014-1; and by the Government of Catalonia under 2017SGR1551. C.V. is the recipient of a grant from the Hospital Clinic i Universitari of Barcelona ("Premi Fi de Residencia 2018-2019").
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Individual Categorisation of Glucose Profiles Using Compositional Data Analysis

  • Biagi, L.
  • Bertachi, A.
  • Giménez, M.
  • Conget, I.
  • Martín-Fernández, Josep Antoni
  • Vehí, Josep
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] The aim of this study was to apply a methodology based on compositional data analysis (CoDA) to categorise glucose profiles obtained from continuous glucose monitoring systems. The methodology proposed considers complete daily glucose profiles obtained from six patients with type 1 diabetes (T1D) who had their glucose monitored for eight weeks. The glucose profiles were distributed into the time spent in six different ranges. The time in one day is finite and limited to 24h, and the times spent in each of these different ranges are co-dependent and carry only relative information; therefore, CoDA is applied to these profiles. A K-means algorithm was applied to the coordinates obtained from the CoDA to obtain different patterns of days for each patient. Groups of days with relatively high time in the hypo and/or hyperglycaemic ranges and with different glucose variability were observed. Using CoDA of time in different ranges, individual glucose profiles were categorised into groups of days, which can be used by physicians to detect the different conditions of patients and personalise patient's insulin therapy according to each group. This approach can be useful to assist physicians and patients in managing the day-to-day variability that hinders glycaemic control., The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project has been partially supported by the Spanish Government MINECO through Grants DPI-2016-78831-C2-1-R, DPI2016-78831-C2-2-R, the National Council of Technological and Scientific Development, CNPq Brazil through Grants 202050/2015-7, 207688/2014-1 and EU through FEDER funds.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Unannounced Meals in the Artificial Pancreas: Detection Using Continuous Glucose Monitoring

  • Ramkissoon, C.M.
  • Herrero, Pau
  • Vehí, Josep
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] The artificial pancreas (AP) system is designed to regulate blood glucose in subjects with type 1 diabetes using a continuous glucose monitor informed controller that adjusts insulin infusion via an insulin pump. However, current AP developments are mainly hybrid closed-loop systems that include feed-forward actions triggered by the announcement of meals or exercise. The first step to fully closing the loop in the AP requires removing meal announcement, which is currently the most effective way to alleviate postprandial hyperglycemia due to the delay in insulin action. Here, a novel approach to meal detection in the AP is presented using a sliding window and computing the normalized cross-covariance between measured glucose and the forward difference of a disturbance term, estimated from an augmented minimal model using an Unscented Kalman Filter. Three different tunings were applied to the samemeal detection algorithm: (1) a high sensitivity tuning, (2) a trade-off tuning that has a high amount of meals detected and a low amount of false positives (FP), and (3) a low FP tuning. For the three tunings sensitivities 99 +/- 2%, 93 +/- 5%, and 47 +/- 12% were achieved, respectively. A sensitivity analysis was also performed and found that higher carbohydrate quantities and faster rates of glucose appearance result in favorable meal detection outcomes., This work was funded by the Spanish Government through grants DPI2016-78831-C2-1-R and DPI2016-78831-C2-2-R, the University of Girona through grant BR2014/51, and the European Union through Fondo Europeo de Desarrollo Regional (FEDER) Funds.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Extensive assessment of blood glucose monitoring during postprandial period and its impact on closed-loop performance

  • Biagi, L.
  • Hirata-Bertachi, A.
  • Conget, I.
  • Quirós, C.
  • Giménez, M.
  • Ampudia-Blasco, F.J.
  • Rossetti, P.
  • Vehí, J.
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background: Closed-loop (CL) systems aims to outperform usual treatments in blood glucose control and continuous glucose monitors (CGM) are a key component in such systems. Meals represents one of the main disturbances in blood glucose control, and postprandial period (PP) is a challenging situation for both CL system and CGM accuracy. Methods: We performed an extensive analysis of sensor¿s performance by numerical accuracy and precision during PP, as well as its influence in blood glucose control under CL therapy. Results: During PP the mean absolute relative difference (MARD) for both sensors presented lower accuracy in the hypoglycemic range (19.4 ± 12.8%) than in other ranges (12.2 ± 8.6% in euglycemic range and 9.3 ± 9.3% in hyperglycemic range). The overall MARD was 12.1 ± 8.2%. We have also observed lower MARD for rates of change between 0 and 2 mg/dl. In CL therapy, the 10 trials with the best sensor spent less time in hypoglycemia (PG < 70 mg/dl) than the 10 trials with the worst sensors (2 ± 7 minutes vs 32 ± 38 minutes, respectively). Conclusions: In terms of accuracy, our results resemble to previously reported. Furthermore, our results showed that sensors with the lowest MARD spent less time in hypoglycemic range, indicating that the performance of CL algorithm to control PP was related to sensor accuracy., The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project has been partially supported by the Spanish Government through Grants DPI 2013-46982-C2-1-R, DPI 2016-78831-C2-1-R, DPI 2013-46982-C2-2-R, and DPI 2016-78831-C2-2-R, the National Council of Technological and Scientific Development, CNPq Brazil through Grants 202050/2015-7 and 207688/2014-1.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Accuracy of Continuous Glucose Monitoring before, during, and after Aerobic and Anaerobic Exercise in Patients with Type 1 Diabetes Mellitus

  • Biagi, L.
  • Bertachi, A.
  • Quirós, C.
  • Giménez, M.
  • Conget, I.
  • Vehí, Josep
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Continuous glucose monitoring (CGM) plays an important role in treatment decisions for patients with type 1 diabetes under conventional or closed-loop therapy. Physical activity represents a great challenge for diabetes management as well as for CGM systems. In this work, the accuracy of CGM in the context of exercise is addressed. Six adults performed aerobic and anaerobic exercise sessions and used two Medtronic Paradigm Enlite-2 sensors under closed-loop therapy. CGM readings were compared with plasma glucose during different periods: one hour before exercise, during exercise, and four hours after the end of exercise. In aerobic sessions, the median absolute relative difference (MARD) increased from 9.5% before the beginning of exercise to 16.5% during exercise (p < 0.001), and then decreased to 9.3% in the first hour after the end of exercise (p < 0.001). For the anaerobic sessions, the MARD before exercise was 15.5% and increased without statistical significance to 16.8% during exercise realisation (p = 0.993), and then decreased to 12.7% in the first hour after the cessation of anaerobic activities (p = 0.095). Results indicate that CGM might present lower accuracy during aerobic exercise, but return to regular operation a few hours after exercise cessation. No significant impact for anaerobic exercise was found., This project was partially supported by the Spanish Government through grants DPI2013-46982-C2-1-R, DPI2013-46982-C2-2-R, DPI2016-78831-C2-1-R, and DPI2016-78831-C2-2-R, and by the National Council of Technological and Scientific Development, CNPq Brazil through grants 202050/2015-7 and 207688/2014-1.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A New Blood Glucose Control Scheme for Unannounced Exercise in Type 1 Diabetic Subjects

  • Beneyto, Aleix
  • Bertachi, Arthur
  • Vehí, Josep
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] The artificial pancreas (AP) system or closed-loop blood glucose (BG) regulation is a technological advancement that aims to relieve diabetic subjects from their current decision-making burden while tightening their BG levels. However, large disturbances such as meals and exercise still pose great challenges to a fully closed-loop system. In this paper, the problem of BG regulation with unannounced physical activity for type 1 diabetic subjects is addressed. We use a coordinated control strategy with insulin infusion and extra carbohydrates (CHO) for hypoglycemia avoidance. The insulin algorithm is based on a proportional-derivative controller with insulin feedback and the so-called safety auxiliary feedback element (SAFE) layer, and the algorithm for CHO is based on a predictive, quantified proportional-derivative controller. The UVa/Padua simulator glucose-insulin model is modified to include the effects of physical activity and is used to test the new AP. We consider scenarios where the subject does not announce physical activity and with challenging meals. Then, we analyze the performance and robustness of the combined insulin and CHO recommender system and compare them to the insulin-only controller. The simulation results show that the new AP system is able to mitigate daily hypoglycemia episodes (0.9 versus 0.2, p < 0.01) and increase the time in range during day (91.5% versus 92.4%, p < 0.01) without increasing the time above 180 mg/dl (6.3% versus 6.4%, p > 0.05)., This work was supported in part by the Ministerio de Economia, Industria y Competitividad under Grant DPI2016-78831-C2-1-R and Grant DPI2016-78831-C2-2-R, in part by the Autonomous Government of Catalonia under Grant 2017 SGR 1551, in part by the Ministerio de Educacion, Cultura y Deporte under Grant FPU0244 2015, in part by the National Counsel of Technological and Scientific Development, CNPq, Brazil, under Grant 207688/2014-1, and in part EU through FEDER funds. Recommended by Associate Editor D. E. Rivera.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Artificial Intelligence for Diabetes Management and Decision Support: Literature Review

  • Contreras, Ivan
  • Vehí, Josep
Artificial intelligence methods in combination with the latest technologies, including medical devices, mobile computing, and sensor technologies, have the potential to enable the creation and delivery of better management services to deal with chronic diseases. One of the most lethal and prevalent chronic diseases is diabetes mellitus, which is characterized by dysfunction of glucose homeostasis. Objective: The objective of this paper is to review recent efforts to use artificial intelligence techniques to assist in the management of diabetes, along with the associated challenges. Methods: A review of the literature was conducted using PubMed and related bibliographic resources. Analyses of the literature from 2010 to 2018 yielded 1849 pertinent articles, of which we selected 141 for detailed review. Results: We propose a functional taxonomy for diabetes management and artificial intelligence. Additionally, a detailed analysis of each subject category was performed using related key outcomes. This approach revealed that the experiments and studies reviewed yielded encouraging results. Conclusions: We obtained evidence of an acceleration of research activity aimed at developing artificial intelligence-powered tools for prediction and prevention of complications associated with diabetes. Our results indicate that artificial intelligence methods are being progressively established as suitable for use in clinical daily practice, as well as for the self-management of diabetes. Consequently, these methods provide powerful tools for improving patients’ quality of life, This work was funded by the Spanish Government through grant DPI2016-78831-C2-2-R and the European Union through Fondo Europeo de Desarrollo Regional (FEDER)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Impact of Use Frequency of a Mobile Diabetes Management App on Blood Glucose Control: Evaluation Study

  • Vehí, Josep
  • Regincós i Isern, Jordi
  • Parcerisas Albés, Adrià
  • Calm i Puig, Remei
  • Contreras, Ivan
Technology has long been used to carry out self-management as well as to improve adherence to treatment in people with diabetes. However, most technology-based apps do not meet the basic requirements for engaging patients. Objective: This study aimed to evaluate the effect of use frequency of a diabetes management app on glycemic control. Methods: Overall, 2 analyses were performed. The first consisted of an examination of the reduction of blood glucose (BG) mean, using a randomly selected group of 211 users of the SocialDiabetes app (SDA). BG levels at baseline, month 3, and month 6 were calculated using the intercept of a regression model based on data from months 1, 4, and 7, respectively. In the second analysis, the impact of low and high BG risk was examined. A total of 2692 users logging SDA ≥5 days/month for ≥6 months were analyzed. The highest quartile regarding low blood glucose index (LBGI) and high blood glucose index (HBGI) at baseline (t1) was selected (n=74 for group A; n=440 for group B). Changes in HBGI and LBGI at month 6 (t2) were analyzed. Results: For analysis 1, baseline BG results for type 1 diabetes mellitus (T1DM) groups A and B were 213.61 (SD 31.57) mg/dL and 206.43 (SD 18.65) mg/dL, respectively, which decreased at month 6 to 175.15 (SD 37.88) mg/dL and 180.6 (SD 40.47) mg/dL, respectively. For type 2 diabetes mellitus (T2DM), baseline BG was 218.77 (SD 40.18) mg/dL and 232.55 (SD 46.78) mg/dL, respectively, which decreased at month 6 to 160.51 (SD 39.32) mg/dL and 173.14 (SD 52.81) mg/dL for groups A and B, respectively. This represents a reduction of estimated A1c (eA1c) of approximately 1.3% (P<.001) and 0.9% (P=.001) for T1DM groups A and B, respectively, and 2% (P<.001) for both A and B T2DM groups, respectively. For analysis 2, T1DM baseline LBGI values for groups A and B were 5.2 (SD 3.9) and 4.4 (SD 2.3), respectively, which decreased at t2 to 3.4 (SD 3.3) and 3.4 (SD 1.9), respectively; this was a reduction of 34.6% (P=.005) and 22.7% (P=.02), respectively. Baseline HBGI values for groups A and B were 12.6 (SD 4.3) and 10.6 (SD 4.03), respectively, which decreased at t2 to 9.0 (SD 6.5) and 8.6 (SD 4.7), respectively; this was a reduction of 30% (P=.001) and 22% (P=.003), respectively. Conclusions: A significant reduction in BG was found in all groups, independent of the use frequency of the app. Better outcomes were found for T2DM patients. A significant reduction in LBGI and HBGI was found in all groups, regardless of the use frequency of the app. LBGI and HBGI indices of both groups tend to have similar values after 6 months of app use, This study was partially supported by the Spanish Ministry of Science and Innovation under grant DPI2016-78831-C2-2-R and by the Autonomous Government of Catalonia under grant 2017 SGR 1551
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Dynamic Rule-Based Algorithm to Tune Insulin-on-Board Constraints for a Hybrid Artificial Pancreas System

  • Bertachi, Arthur Hirata
  • Biagi, Lyvia
  • Beneyto Tantiña, Aleix
  • Vehí, Josep
The artificial pancreas (AP) is a system intended to control blood glucose levels through automated insulin infusion, reducing the burden of subjects with type 1 diabetes to manage their condition. To increase patients’ safety, some systems limit the allowed amount of insulin active in the body, known as insulin-on-board (IOB). The safety auxiliary feedback element (SAFE) layer has been designed previously to avoid overreaction of the controller and thus avoiding hypoglycemia. In this work, a new method, so-called “dynamic rule-based algorithm,” is presented in order to adjust the limits of IOB in real time. The algorithm is an extension of a previously designed method which aimed to adjust the limits of IOB for a meal with 60 grams of carbohydrates (CHO). The proposed method is intended to be applied on hybrid AP systems during 24 h operation. It has been designed by combining two different strategies to set IOB limits for different situations: (1) fasting periods and (2) postprandial periods, regardless of the size of the meal. The UVa/Padova simulator is considered to assess the performance of the method, considering challenging scenarios. In silico results showed that the method is able to reduce the time spent in hypoglycemic range, improving patients’ safety, which reveals the feasibility of the approach to be included in different control algorithms, This work has been partially funded by the Spanish Government (grant no. DPI2016-78831-C2-2-R), National Counsel of Technological and Scientific Development, CNPq-Brazil (grant nos. 207688/2014-1 and 202050/2015-7), and Formación de Professorado Universitario (grant no. FPU0244 2015)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Accuracy of Continuous Glucose Monitoring before, during, and after Aerobic and Anaerobic Exercise in Patients with Type 1 Diabetes Mellitus

  • Biagi, Lyvia
  • Bertachi, Arthur Hirata
  • Quirós, Carmen
  • Giménez, Marga
  • Conget, Ignacio
  • Bondia, Jorge
  • Vehí, Josep
Continuous glucose monitoring (CGM) plays an important role in treatment decisions for patients with type 1 diabetes under conventional or closed-loop therapy. Physical activity represents a great challenge for diabetes management as well as for CGM systems. In this work, the accuracy of CGM in the context of exercise is addressed. Six adults performed aerobic and anaerobic exercise sessions and used two Medtronic Paradigm Enlite-2 sensors under closed-loop therapy. CGM readings were compared with plasma glucose during different periods: one hour before exercise, during exercise, and four hours after the end of exercise. In aerobic sessions, the median absolute relative difference (MARD) increased from 9.5% before the beginning of exercise to 16.5% during exercise (p < 0.001), and then decreased to 9.3% in the first hour after the end of exercise (p < 0.001). For the anaerobic sessions, the MARD before exercise was 15.5% and increased without statistical significance to 16.8% during exercise realisation (p = 0.993), and then decreased to 12.7% in the first hour after the cessation of anaerobic activities (p = 0.095). Results indicate that CGM might present lower accuracy during aerobic exercise, but return to regular operation a few hours after exercise cessation. No significant impact for anaerobic exercise was found, This project was partially supported by the Spanish Government through grants DPI2013-46982-C2-1-R, DPI2013-46982-C2-2-R, DPI2016-78831-C2-1-R, and DPI2016-78831-C2-2-R, and by the National Council of Technological and Scientific Development, CNPq Brazil through grants 202050/2015-7 and 207688/2014-1
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Unannounced Meals in the Artificial Pancreas: Detection Using Continuous Glucose Monitoring

  • Ramkissoon, Charrise Mary
  • Herrero i Viñas, Pau
  • Bondia, Jorge
  • Vehí, Josep
The artificial pancreas (AP) system is designed to regulate blood glucose in subjects with type 1 diabetes using a continuous glucose monitor informed controller that adjusts insulin infusion via an insulin pump. However, current AP developments are mainly hybrid closed-loop systems that include feed-forward actions triggered by the announcement of meals or exercise. The first step to fully closing the loop in the AP requires removing meal announcement, which is currently the most effective way to alleviate postprandial hyperglycemia due to the delay in insulin action. Here, a novel approach to meal detection in the AP is presented using a sliding window and computing the normalized cross-covariance between measured glucose and the forward difference of a disturbance term, estimated from an augmented minimal model using an Unscented Kalman Filter. Three different tunings were applied to the same meal detection algorithm: (1) a high sensitivity tuning, (2) a trade-off tuning that has a high amount of meals detected and a low amount of false positives (FP), and (3) a low FP tuning. For the three tunings sensitivities 99 ± 2%, 93 ± 5%, and 47 ± 12% were achieved, respectively. A sensitivity analysis was also performed and found that higher carbohydrate quantities and faster rates of glucose appearance result in favorable meal detection outcomes, This work was funded by the Spanish Government through grants DPI2016-78831-C2-1-R and DPI2016-78831-C2-2-R, the University of Girona through grant BR2014/51, and the European Union through Fondo Europeo de Desarrollo Regional (FEDER) Funds
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Personalized blood glucose prediction: A hybrid approach using grammatical evolution and physiological models

  • Contreras, Ivan
  • Oviedo Castillo, Silvia
  • Vettoretti, Martina
  • Visentin, Roberto
  • Vehí, Josep
The large patient variability in human physiology and the effects of variables such as exercise or meals challenge current prediction modeling techniques. Physiological models are very precise but they are typically complex and specific physiological knowledge is required. In contrast, data-based models allow the incorporation of additional inputs and accurately capture the relationship between these inputs and the outcome, but at the cost of losing the physiological meaning of the model. In this work, we designed a hybrid approach comprising physiological models for insulin and grammatical evolution, taking into account the clinical harm caused by deviations from the target blood glucose by using a penalizing fitness function based on the Clarke error grid. The prediction models were built using data obtained over 14 days for 100 virtual patients generated by the UVA/Padova T1D simulator. Midterm blood glucose was predicted for the 100 virtual patients using personalized models and different scenarios. The results obtained were promising; an average of 98.31% of the predictions fell in zones A and B of the Clarke error grid. Midterm predictions using personalized models are feasible when the configuration of grammatical evolution explored in this study is used. The study of new alternative models is important to move forward in the development of alarm-and-control applications for the management of type 1 diabetes and the customization of the patient’s treatments. The hybrid approach can be adapted to predict short-term blood glucose values to detect continuous glucose-monitoring sensor errors and to estimate blood glucose values when the continuous glucose-monitoring system fails to provide them, This work was partly supported by the Spanish Ministry of Science and Innovation (grants DPI 2013-46982-C2-2-R and DPI2016-78831-C2-2-R), the People program (Marie Sklodowska-Curie Actions) of the European Union Seventh Framework Programme (FP7/2007-2013) with agreement (No. 600388) (TECNIOspring programme) of the REA and the Agencia per a la Competitivitat de L’Empresa (ACCIO´), and by the Spanish Government through contract ES-2014-068289
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Probabilistic Model of Transition between Categories of Glucose Profiles in Patients with Type 1 Diabetes Using a Compositional Data Analysis Approach

  • Biagi, Lyvia
  • Bertachi, Arthur Hirata
  • Giménez, Marga
  • Conget, Ignacio
  • Bondia, Jorge
  • Martín Fernández, Josep Antoni
  • Vehí, Josep
The time spent in glucose ranges is a common metric in type 1 diabetes (T1D). As the time in one day is finite and limited, Compositional Data (CoDa) analysis is appropriate to deal with times spent in different glucose ranges in one day. This work proposes a CoDa approach applied to glucose profiles obtained from six T1D patients using continuous glucose monitor (CGM). Glucose profiles of 24-h and 6-h duration were categorized according to the relative interpretation of time spent in different glucose ranges, with the objective of presenting a probabilistic model of prediction of category of the next 6-h period based on the category of the previous 24-h period. A discriminant model for determining the category of the 24-h periods was obtained, achieving an average above 94% of correct classification. A probabilistic model of transition between the category of the past 24-h of glucose to the category of the future 6-h period was obtained. Results show that the approach based on CoDa is suitable for the categorization of glucose profiles giving rise to a new analysis tool. This tool could be very helpful for patients, to anticipate the occurrence of potential adverse events or undesirable variability and for physicians to assess patients’ outcomes and then tailor their therapies, This project has been partially supported by the Spanish Government, Ministerio de Economía y Competitividad (MINECO) (Grants DPI2016-78831-C2-1-R, DPI2016-78831-C2-2-R, RTI2018-095518-B-C21), Agencia Estatal de Investigación (PID2019-107722RB-C21/ AEI/10.13039/501100011033), the National Council of Technological and Scientific Development, CNPq Brazil through Grants 202050/2015-7, 207688/2014-1 and EU through FEDER funds
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Long-Term Glucose Forecasting Using a Physiological Model and Deconvolution of the Continuous Glucose Monitoring Signal

  • Liu, Chengyuan
  • Vehí, Josep
  • Avari, Parizad
  • Reddy, Monika
  • Oliver, Nick
  • Georgiou, Pantelis
  • Herrero i Viñas, Pau
Blood glucose forecasting in type 1 diabetes (T1D) management is a maturing field with numerous algorithms being published and a few of them having reached the commercialisation stage. However, accurate long-term glucose predictions (e.g., >60 min), which are usually needed in applications such as precision insulin dosing (e.g., an artificial pancreas), still remain a challenge. In this paper, we present a novel glucose forecasting algorithm that is well-suited for long-term prediction horizons. The proposed algorithm is currently being used as the core component of a modular safety system for an insulin dose recommender developed within the EU-funded PEPPER (Patient Empowerment through Predictive PERsonalised decision support) project. (2) Methods: The proposed blood glucose forecasting algorithm is based on a compartmental composite model of glucose–insulin dynamics, which uses a deconvolution technique applied to the continuous glucose monitoring (CGM) signal for state estimation. In addition to commonly employed inputs by glucose forecasting methods (i.e., CGM data, insulin, carbohydrates), the proposed algorithm allows the optional input of meal absorption information to enhance prediction accuracy. Clinical data corresponding to 10 adult subjects with T1D were used for evaluation purposes. In addition, in silico data obtained with a modified version of the UVa-Padova simulator was used to further evaluate the impact of accounting for meal absorption information on prediction accuracy. Finally, a comparison with two well-established glucose forecasting algorithms, the autoregressive exogenous (ARX) model and the latent variable-based statistical (LVX) model, was carried out. (3) Results: For prediction horizons beyond 60 min, the performance of the proposed physiological model-based (PM) algorithm is superior to that of the LVX and ARX algorithms. When comparing the performance of PM against the secondly ranked method (ARX) on a 120 min prediction horizon, the percentage improvement on prediction accuracy measured with the root mean square error, A-region of error grid analysis (EGA), and hypoglycaemia prediction calculated by the Matthews correlation coefficient, was 18.8%, 17.9%, and 80.9%, respectively. Although showing a trend towards improvement, the addition of meal absorption information did not provide clinically significant improvements. (4) Conclusion: The proposed glucose forecasting algorithm is potentially well-suited for T1D management applications which require long-term glucose predictions, This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement 689810, and by the Spanish Ministry of Science and Innovation under Grant DPI2016-78831-C2-2-R
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Automated blood glucose control in type 1 diabetes: A review of progress and challenges = Control automatizado de la glucosa en la diabetes tipo 1: revisión del progreso y los desafíos

  • Bertachi, Arthur Hirata
  • Ramkissoon, Charrise Mary
  • Bondia, Jorge
  • Vehí, Josep
Since the 2000s, research teams worldwide have been working to develop closedloop (CL) systems able to automatically control blood glucose (BG) levels in patients with type 1 diabetes. This emerging technology is known as artificial pancreas (AP), and its first commercial version just arrived in the market. The main objective of this paper is to present an extensive review of the clinical trials conducted since 2011, which tested various implementations of the AP for different durations under varying conditions. A comprehensive table that contains key information from the selected publications is provided, and the main challenges in AP development and the mitigation strategies used are discussed. The development timelines for different AP systems are also included, highlighting the main evolutions over the clinical trials for each system, Desde los anos ˜ 2000, equipos de investigación de todo el mundo han estado trabajando para desarrollar sistemas de lazo cerrado (LC) capaces de controlar automáticamente los niveles de glucosa en sangre en pacientes con diabetes tipo 1. Esta tecnología emergente se conoce como el páncreas artificial (PA) y la primera versión comercial acaba de llegar al mercado. El objetivo principal de este trabajo es presentar una extensa revisión de los ensayos clínicos realizados desde 2011, en los cuales se han puesto a prueba diversas implementaciones del AP, para diferentes duraciones y bajo diversas condiciones. Presentamos una tabla completa que contiene información clave de las publicaciones seleccionadas y se debaten los principales retos en el desarrollo del páncreas artificial, así como las estrategias de mitigación empleadas. Se incluye también una cronología sobre el desarrollo de los principales sistemas PA destacando las principales evoluciones en los ensayos clínicos, This work has been partially funded by the Spanish Government (DPI 2013-46982-C2-1-R, DPI 2013-46982-C2-2-R, DPI2016-78831-C2-1-R and DPI2016-78831-C2-2-R), the University of Girona (BR2014/51) and the National Counsel of Technological and Scientific Development, CNPq - Brazil (207688/2014-1)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Prediction of Nocturnal Hypoglycemia in Adults with Type 1 Diabetes under Multiple Daily Injections Using Continuous Glucose Monitoring and Physical Activity Monitor

  • Bertachi, Arthur Hirata
  • Viñals, Clara
  • Biagi, Lyvia
  • Contreras, Ivan
  • Vehí, Josep
  • Conget, Ignacio
  • Giménez, Marga
Background: nocturnal hypoglycemia (NH) is one of the most challenging side effects of multiple doses of insulin (MDI) therapy in type 1 diabetes (T1D). This work aimed to investigate the feasibility of a machine-learning-based prediction model to anticipate NH in T1D patients on MDI. (2) Methods: ten T1D adults were studied during 12 weeks. Information regarding T1D management, continuous glucose monitoring (CGM), and from a physical activity tracker were obtained under free-living conditions at home. Supervised machine-learning algorithms were applied to the data, and prediction models were created to forecast the occurrence of NH. Individualized prediction models were generated using multilayer perceptron (MLP) and a support vector machine (SVM). (3) Results: population outcomes indicated that more than 70% of the NH may be avoided with the proposed methodology. The predictions performed by the SVM achieved the best population outcomes, with a sensitivity and specificity of 78.75% and 82.15%, respectively. (4) Conclusions: our study supports the feasibility of using ML techniques to address the prediction of nocturnal hypoglycemia in the daily life of patients with T1D on MDI, using CGM and a physical activity tracker, This work has been partially funded by the Spanish Government (DPI2016-78831-C2-2-R) and the National Council of Technological and Scientific Development, CNPq—Brazil (202050/2015-7 and 207688/2014-1). C.V. is the recipient of a grant from the Hospital Clínic i Universitari of Barcelona (“Premi Fi de Residencia 2018–2019”)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Modeling the Error of the Medtronic Paradigm Veo Enlite Glucose Sensor

  • Biagi, Lyvia
  • Ramkissoon, Charrise Mary
  • Facchinetti, Andrea
  • Leal Moncada, Yenny Teresa
  • Vehí, Josep
Continuous glucose monitors (CGMs) are prone to inaccuracy due to time lags, sensor drift, calibration errors, and measurement noise. The aim of this study is to derive the model of the error of the second generation Medtronic Paradigm Veo Enlite (ENL) sensor and compare it with the Dexcom SEVEN PLUS (7P), G4 PLATINUM (G4P), and advanced G4 for Artificial Pancreas studies (G4AP) systems. An enhanced methodology to a previously employed technique was utilized to dissect the sensor error into several components. The dataset used included 37 inpatient sessions in 10 subjects with type 1 diabetes (T1D), in which CGMs were worn in parallel and blood glucose (BG) samples were analyzed every 15 ± 5 min Calibration error and sensor drift of the ENL sensor was best described by a linear relationship related to the gain and offset. The mean time lag estimated by the model is 9.4 ± 6.5 min. The overall average mean absolute relative difference (MARD) of the ENL sensor was 11.68 ± 5.07% Calibration error had the highest contribution to total error in the ENL sensor. This was also reported in the 7P, G4P, and G4AP. The model of the ENL sensor error will be useful to test the in silico performance of CGM-based applications, i.e., the artificial pancreas, employing this kind of sensor, This project has been partially supported by the Spanish Government through Grants DPI-2013-46982-C2-2-R and DPI-2016-78831-C2-2-R, the National Council of Technological and Scientific Development, CNPq Brazil through Grant 202050/2015-7, the University of Girona through Grant BR2014/51, and the Agency for Management of University and Research Grants of the Government of Catalonia, Spain (Beatriu de Pinós [BP-DGR 2013])